Ingrid Honan

Dr. Ingrid Honan

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2022 in Journal of the American Academy of Child & Adolescent Psychiatry
Verified
Journal Article
Closed access
GBGenevieve Le Bas
Genevieve Le Bas
GYGeorge Youssef
George Youssef
JMJacqui A. Macdonald
Jacqui A. Macdonald
STSamantha Teague
Samantha Teague
RMRichard Mattick
Richard Mattick
DHDelyse Hutchinson
Delyse Hutchinson

1 February 2021 in Journal of Affective Disorders
Verified
Journal Article
Closed access
GBGenevieve A. Le Bas
Genevieve A. Le Bas
GYGeorge J. Youssef
George J. Youssef
JMJacqui A. Macdonald
Jacqui A. Macdonald
RMRichard Mattick
Richard Mattick
STSamantha Teague
Samantha Teague
DHDelyse M. Hutchinson
Delyse M. Hutchinson

4 August 2022 in Journal of Evaluation in Clinical Practice
Verified
Journal Article
Open access
IHIngrid Honan
Ingrid Honan
NSNicole Sharp
Nicole Sharp
SMSarah McIntyre
Sarah McIntyre
HSHayley Smithers‐Sheedy
Hayley Smithers‐Sheedy
IBIsabelle Balde
Isabelle Balde
ELElizabeth A. Laugeson
Elizabeth A. Laugeson
Rationale, Aims and Objectives: Social challenges are common for young adults with autism spectrum disorder (ASD) and/or mild intellectual impairment, yet few evidence‐based interventions exist to address these challenges. PEERS®, the Program for the Education and Enrichment of Relational Skills, has been shown to be effective in improving the social skills of young adults with ASD; however, it requires a significant time commitment for parents of young adults. As such, this mixed‐methods study aimed to investigate the experiences of young adults, parents and PEERS® social coaches participating in an adapted PEERS® program, and to evaluate its acceptability and efficacy.Method: Young adults with ASD and/or mild intellectual impairment participated in a 16‐week PEERS® program. Parents and PEERS® social coaches attended fewer, condensed sessions, where they learnt program content to support the young adults' social skill development at home and in the community. Focus groups were conducted post intervention. Quantitative pre−post assessment using the Social and Emotional Loneliness Scale for Adults, the Test of Young Adult Social Skills Knowledge, and Quality of Socialization Questionnaire‐Young Adults was completed by young adults. The Social Responsiveness Scale Second Edition was completed by young adults and their parents.Result: Qualitative results revealed that, taken together, young adults, parents and PEERS® social coaches all felt that the adapted PEERS® program was ‘challenging, but worth it’. The program was acceptable with a 93% attendance rate across all sessions. Whilst young adults' perceptions of their own social functioning did not change post‐intervention, their knowledge of social skills content improved significantly (p < 0.05). Parent perceptions of young adults' social responsiveness also improved (p < 0.05).Conclusions: Social skill knowledge, social responsiveness, and social engagement improved significantly following the completion of the adapted PEERS® program. It was deemed acceptable and worthwhile by young adults, their parents and PEERS® social coaches.

28 March 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
IHIngrid Honan
Ingrid Honan
EWEmma Waight
Emma Waight
JBJoan Bratel
Joan Bratel
FGFiona Given
Fiona Given
NBNadia Badawi
Nadia Badawi
HSHayley Smithers-Sheedy
Hayley Smithers-Sheedy
Emotion regulation difficulties are associated with many neurological conditions and negatively impact daily function. Yet little is known about emotion regulation in adults with cerebral palsy (CP). Our aim was to investigate emotion regulation in adults with CP and its relationship with condition-related and/or socio-demographic factors. In a cross-sectional study of adults with CP, participants completed a survey containing the Difficulties in Emotion Regulation Scale (DERS), Depression Anxiety and Stress Scale-21 (DASS-21), and socio-demographic and condition-related questions. Descriptive statistics, chi-squared and Mann–Whitney tests were performed. Of the 42 adults with CP (x31.5 years, SD13.5) that were tested, 38 had within normal limits DERS total scores; however, a significantly higher proportion of participants experienced elevated scores (i.e., more difficulties with emotion regulation) than would be expected in the general population across five of the six DERs subdomains. Moderate–extremely severe depression and anxiety symptoms were reported by 33% and 60% of participants, respectively. The DERS total scores for participants with elevated depression, anxiety, and stress scores were significantly higher than the DERS totals score for those without elevated depression, anxiety, and stress scores. DERS and DASS-21 scores did not differ significantly by condition-related nor socio-demographic characteristics. In conclusion, emotion regulation difficulties were associated with elevated symptoms of depression and anxiety, which were overrepresented in the adults with CP participating in this study.

17 August 2021 in Developmental Medicine & Child Neurology
Verified
Journal Article
Open access
PDF file
IHIngrid Honan
Ingrid Honan
Megan Finch-EdmondsonMegan Finch-Edmondson
Megan Finch-Edmondson
CIChristine Imms
Christine Imms
INIona Novak
Iona Novak
AHAmy Hogan
Amy Hogan
NBNadia Badawi
Nadia Badawi
In the field of disability research and advocacy, the notion of ‘cures’ is contentious. Cerebral palsy (CP) is no exception. In this narrative review, we combine perspectives gained during community consultation undertaken for the Australian and New Zealand Cerebral Palsy Strategy, 2020 with those published in the scientific and grey literature to understand whether ‘cures for CP’ is a reasonable and appropriate goal. We frame these perspectives through the lens of several ethical principles central to the discussion. These include maintaining hope while also being realistic, sensitivity to sharply different viewpoints amongst people with disability and their families, and responding to community priorities, societal attitudes, and identity. Through this exploration of the literature and perspectives, we arrived at a definition of ‘cures for CP’ that is pluralized and focuses on functional improvement and/or symptom reduction whilst still acknowledging the potential for neural repair/regeneration strategies.

9 December 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Megan Finch-EdmondsonMegan Finch-Edmondson
Megan Finch-Edmondson
Madison Claire Badawy PatonMadison Claire Badawy Paton
Madison Claire Badawy Paton
IHIngrid Honan
Ingrid Honan
PKPetra Karlsson
Petra Karlsson
CSCandice Stephenson
Candice Stephenson
INIona Novak
Iona Novak
Cell therapies are an emergent treatment for cerebral palsy (CP) with promising evidence demonstrating efficacy for improving gross motor function. However, families value improvements in a range of domains following intervention and the non-motor symptoms, comorbidities and complications of CP can potentially be targeted by cell therapies. We conducted a scoping review to describe all outcomes that have been reported in cell therapy studies for CP to date, and to examine what instruments were used to capture these. Through a systematic search we identified 54 studies comprising 2066 participants that were treated with a range of cell therapy interventions. We categorized the reported 53 unique outcome instruments and additional descriptive measures into 10 categories and 12 sub-categories. Movement and Posture was the most frequently reported outcome category, followed by Safety, however Quality of Life, and various prevalent comorbidities and complications of CP were infrequently reported. Notably, many outcome instruments used do not have evaluative properties and thus are not suitable for measuring change following intervention. We provide a number of recommendations to ensure that future trials generate high-quality outcome data that is aligned with the priorities of the CP community.